Park Avenue Securities’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Park Avenue Securities’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-641	Closed	-$203K	–	1424
2023 Q4	$203K	Buy	+641	New	+$125K	﹤0.01%	1299

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Park Avenue Securities's KRTX Position: Q1 2024 in Review

Park Avenue Securities sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 641 shares — an estimated $203K sold.

Park Avenue Securities first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $203K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Park Avenue Securities reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Park Avenue Securities sold 641 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $203K.
Park Avenue Securities first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Park Avenue Securities's Karuna Therapeutics, Inc. Common Stock position peaked at $203K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Park Avenue Securities's 13F filing for Q1 2024, filed 10 Apr 2024.